BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 1010 | Download: 1194
Publication Name World Journal of Gastroenterology
Manuscript ID 3271
Country Italy
Received
2013-04-18 08:47
Peer-Review Started
2013-04-18 17:21
To Make the First Decision
2013-05-14 18:44
Return for Revision
2013-05-17 11:55
Revised
2013-06-21 23:08
Second Decision
2013-08-06 13:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-06 23:00
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-11-04 06:09
Typeset the Manuscript
2013-11-23 14:59
Publish the Manuscript Online
2013-12-18 10:39
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Role of the advanced glycation end products receptor in Crohn’s disease inflammation
Manuscript Source Invited Manuscript
All Author List Rachele Ciccocioppo, Alessandro Vanoli, Catherine Klersy, Venerina Imbesi, Vincenzo Boccaccio, Rachele Manca, Elena Betti, Giuseppina Cristina Cangemi, Elena Strada, Roberta Besio, Antonio Rossi, Colomba Falcone, Sandro Ardizzone, Paolo Fociani, Piergiorgio Danelli and Gino Roberto Corazza
Funding Agency and Grant Number
Funding Agency Grant Number
Direzione Scientifica, Fondazione IRCCS Policlinico San Matteo-Progetto di Ricerca Corrente 08061307/11
Corresponding Author Rachele Ciccocioppo, MD, Department of Internal Medicine, Center for the Study and Cure of Inflammatory Bowel Disease, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy. rachele.ciccocioppo@unipv.it
Key Words Apoptosis; Crohn’s disease; Chronic inflammation; Immunohistochemistry; Receptor for advanced glycation end products; Tumor necrosis factor-α
Core Tip Receptor for the advanced glycation end products (RAGE) is a multiligand transmembrane receptor whose activation sustains chronic inflammation. The inhibition of RAGE-ligand interaction has proved successful in an experimental model of Crohn’s disease (CD). Our work shows an up-regulation of RAGE expression in both inflamed and non-inflamed mucosa of CD patients in comparison to healthy tissue from control subjects. Moreover, RAGE blocking significantly affects both the apoptotic rate and tumor necrosis factor-α secretion of mucosal immune cells, which are considered to be leading mechanisms in the chronic inflammation of CD. These findings pave the way for a possible use of RAGE blocking agents as a new therapeutic tool in this disabling condition.
Publish Date 2013-12-18 10:39
Citation Ciccocioppo R, Vanoli A, Klersy C, Imbesi V, Boccaccio V, Manca R, Betti E, Cangemi GC, Strada E, Besio R, Rossi A, Falcone C, Ardizzone S, Fociani P, Danelli P, Corazza GR. Role of the advanced glycation end products receptor in Crohn’s disease inflammation. World J Gastroenterol 2013; 19(45): 8269-8281
URL http://www.wjgnet.com/1007-9327/full/v19/i45/8269.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i45.8269
Full Article (PDF) WJG-19-8269.pdf
Manuscript File 3271-Review.doc
Answering Reviewers 3271-Answering reviewers.pdf
Copyright License Agreement 3271-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 3271-Language certificate.pdf
Peer-review Report 3271-Peer reviews.pdf
Scientific Editor Work List 3271-Scientific editor work list.doc